- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03264729
The Acute Effect of Isotonic Versus Isometric Exercise Versus Walking on Pain in Individuals With Plantar Fasciopathy
The Acute Effect of Isotonic Versus Isometric Exercise Versus Walking on Pain in Individuals With Plantar Fasciopathy: a Randomised, Participant-blinded, Cross-over Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be required to attend three sessions (isometric, isotonic, or walking) within a maximum of two weeks. The order in which the participant completes the sessions will be randomised.There will be a minimum of 48 hours between sessions. To account for potential time of day differences in terms of pain, all sessions will be performed within ±1 hour (e.g. if the first session is performed at 10 AM the remaining two sessions will be performed between 9 and 11 AM). After diagnosis, randomisation of the order of which the sessions will be performed, and have their pain during an aggravating activity examined (aggravating activities will be static stance, half squat or heel raise). Subsequently the participants will be instructed in performing either isotonic or isometric heel raise or walking, (determined according to the randomisation) by a physiotherapist.
All statistical analyses will be performed according to a pre-established analysis plan using STATA ver. 14. The assumption of negligible carryover effects is investigated with a preliminary test. The primary analysis will test the presence of a difference in EIH between isotonic and isometric exercise and walking and a 3 X 2 repeated measures ANOVA will be performed. Independent factors will be exercise type (isometric vs. isotonic vs. walking) and time (pre vs. post). If an interaction is found, post-hoc paired t-tests will be performed. The standardised mean difference (effect size) and its confidence intervals will be calculated and presented in a forest plot. Apriori it has been determined that no conclusions will be made favouring either of the exercises nor walking if pain is reduced less than the clinically important difference of 19 mm VAS. In addition, the proportion of clinically relevant pain reductions (i.e. a pain reduction of at least 19 mm VAS) will be calculated. EIH by pain experienced during the aggravating activity before the exercises and walking will also be presented in a plot.
Secondary analyses using a 3 X 2 repeated measures ANOVAs will test if there is a difference in the thickness of the plantar fascia and a difference in PPTs from before to after either of the exercises or walking and a difference in pain experienced during the exercises or walking. If interactions are found post-hoc paired t-tests will be performed. A paired t-test will be performed to investigate potential differences in plantar fascia thickness from before to after the initial PPT and pain aggravating activity are performed. Effect sizes will be calculated for the difference in pressure pain threshold and plantar fascia thickness. The association between thickness of the plantar fascia and the difference in pain from before to after the exercise activities will be investigated using Pearson's correlation coefficient.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aalborg East, Denmark, 9220
- Research unit for general practice
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- History of inferior heel pain for at least three months before enrolment
- Pain on palpation of the medial calcaneal tubercle or the proximal plantar fascia
- Thickness of the plantar fascia of 4.0 mm or greater
- Pain during at least one of three pain aggravating activities (static stance, half squat and heel raise)
- Mean heel pain of ≥ 20 mm on a 100 mm VAS [0mm = no pain, 100mm = worst pain imaginable] during the past week
Exclusion Criteria:
- Below 18 years of age
- History of inflammatory systemic diseases
- Pain or stiffness in the 1st metatarsophalangeal joint to an extent where the exercises cannot be performed
- Prior heel surgery
- Pregnancy
- Pain medication
- Corticosteroid injection for plantar fasciopathy within the past six months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Isometric exercise
|
The isometric exercise is performed standing with the forefoot on a step.
The participant is instructed to stand still with the ankle joint in neutral and hold this position.
Supporting oneself for balance by placing the hands on a wall or a rail is allowed.
The participant performs 5 sets of 45-second isometric holds.
The load used is the heaviest possible load that the participant is able to withstand for 1 minute.
As with the isotonic exercise, if the participant's body weight is inadequate the participant is fitted with a backpack with books and/or weights.
|
|
Active Comparator: Isotonic exercise
|
The isotonic exercise is performed standing with the forefoot on a step. The toes are maximally dorsi-flexed by placing a towel underneath them. The participant is instructed to perform a heel-raise to a maximal plantar flexion in the ankle joint, and afterwards to lower the heel to maximal dorsi flexion. Supporting oneself for balance by placing the hands on a wall or a rail is allowed. The participant performs 4 sets of 8 repetitions with a load of 8RM. The contraction time is 3s concentric, 2s isometric and 3s eccentric and will be guided by a metronome. If the participant's body weight is inadequate to reach sufficient loading during the exercises the participant is fitted with a backpack with books and/or weights. |
|
Active Comparator: Walking
|
The walking will be performed barefoot and the participant will be instructed in walking at a pace similar to the pace they would use when walking around in their home.
The duration of the walking session will be four minutes to match the duration during the exercises.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in pain
Time Frame: Immediately before and after each exercise/walking
|
This is measured during an aggravating task on a 100 mm VAS, where 0 mm is no pain and 100 mm is worst pain imaginable and is also referred to as exercise-induced hypoalgesia (EIH)
|
Immediately before and after each exercise/walking
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in pressure pain threshold
Time Frame: Immediately before and after each exercise/walking
|
Measured on the tenderest spot under the heel by an algometer in kPa
|
Immediately before and after each exercise/walking
|
|
Change in thickness of the plantar fascia
Time Frame: Immediately before and after each exercise/walking
|
Measured by ultrasonography in mm
|
Immediately before and after each exercise/walking
|
|
Pain
Time Frame: During each exercise/walking
|
Measured on a 100 mm VAS, where 0 mm is no pain and 100 mm is worst pain imaginable.
|
During each exercise/walking
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Henrik Riel, M.Sc., Research Unit for General Practice in Aalborg, Department of Clinical Medicine, Aalborg University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- N-20170021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Plantar Fasciopathy
-
Aalborg UniversityCenter for General Practice at Aalborg UniversityCompletedPlantar FasciopathyDenmark
-
Aalborg UniversityCompletedHeavy-slow Resistance Training and Ultrasound-guided Corticosteroid Injection in Plantar FasciopathyPlantar Fasciopathy | Plantar Heel PainDenmark
-
Elisabetta BrigoRecruitingPlantar Fasciitis | Plantar Fasciopathy | Plantar Fasciitis, Chronic | Heel PainIreland
-
University of British ColumbiaCompletedPlantar Fasciitis | Plantar FasciopathyCanada
-
University of British ColumbiaBioElectronics CorporationCompleted
-
Dynasplint Systems, Inc.TerminatedPlantar Fasciitis | Plantar FasciopathyUnited States
-
Aalborg UniversityCompleted
-
Aalborg UniversityCompletedPlantar FasciopathyDenmark
-
University of SevilleNot yet recruitingPlantar Fasciopathy | Plantar Fasciitis of Both FeetSpain
-
Sohag UniversityNot yet recruitingin Cases of Chronic Resistant Plantar FasciopathyEgypt
Clinical Trials on Isometric exercise
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of ValenciaCompletedRotator Cuff TendinitisSpain
-
Firat UniversityNot yet recruitingPatellofemoral Pain Syndrome | Anterior Knee PainTurkey (Türkiye)
-
Riphah International UniversityCompletedHealthy AdolescentsPakistan
-
University of Texas at AustinCompleted
-
Augenabteilung Allgemeines Krankenhaus LinzCompleted
-
Humboldt-Universität zu BerlinCharite University, Berlin, GermanyCompletedTendinopathyGermany
-
Universidade do PortoAveiro UniversityRecruitingResistant HypertensionPortugal